Literature DB >> 6789846

The interference of leukocytes and platelets with measurement of clucose-6-phosphate dehydrogenase activity of erythrocytes with low activity variants of the enzyme.

A Morelli, U Benatti, L Lenzerini, B Sparatore, F Salomino, E Melloni, M Michetti, S Pontremoli, A De Flora.   

Abstract

Complete removal of leukocytes and platelets from whole blood showed that the glucose-6-phosphage dehydrogenase (G6PD) activity in "pure" erythrocytes from G6PD deficient hemizygous Sardinian subjects is consistently lower than reported in the literature. Thus, although non of 27 hemizygous subjects showed undetectable erythrocyte G6PD activity, their levels ranged between 0.0015 and 0.008 IU/g Hb, as compared with a mean value of 4.5 IU/g Hb in normal subjects. Most of the biochemical peoperties that were formerly ascribed to erythrocyte G6PD appear to be those of the enzyme from contaminating leukocytes and (or) platelets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789846

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Selectivity of proteases as a basis for tissue distribution of enzymes in hereditary deficiencies.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

2.  6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.

Authors:  E Beutler; W Kuhl; T Gelbart
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Encapsulation of adriamycin in human erythrocytes.

Authors:  A De Flora; U Benatti; L Guida; E Zocchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study.

Authors:  N Orzalesi; M Fossarello; R Sorcinelli; U Schlich
Journal:  Doc Ophthalmol       Date:  1984-05-30       Impact factor: 2.379

5.  Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii.

Authors:  Y E Hsia; F Miyakawa; J Baltazar; N S Ching; J Yuen; B Westwood; E Beutler
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

6.  Incorporating G6PD genotyping to identify patients with G6PD deficiency.

Authors:  Sarah A Morris; Kristine R Crews; Randall T Hayden; Clifford M Takemoto; Wenjian Yang; Donald K Baker; Ulrich Broeckel; Mary V Relling; Cyrine E Haidar
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

7.  Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.

Authors:  S De Flora; C Bennicelli; F D'Agostini; A Izzotti; A Camoirano
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

8.  Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.

Authors:  Katherine M Robinson; Wenjian Yang; Cyrine E Haidar; Jane S Hankins; Dennis W Jay; Nancy Kornegay; Jeffrey E Rubnitz; Ulrich Broeckel; Cheng Cheng; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  Pharmacogenomics J       Date:  2018-09-12       Impact factor: 3.550

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.